Chief Scientific Officer, Phoreus Biotechnology, Inc.
Branched Amphipathic Peptide Capsules (BAPC) is a unique delivery system that can be applied to animal and human health as well as population control in pest, plant and animal species. This novel nanomaterial made up of natural biodegradable amino acids has the capacity to improve delivery capabilities of new vaccines, cancer therapies, alterative antibiotics, agricultural biopesticides, and potentially, a cost-effective water purification system. Initial utilization of the BAPC technology will be as a gene transfection agent for research applications. Early studies have indicated that BAPCs effectively transport and provide intracellular delivery of a variety of nucleic acids such as dsRNA, plasmids, and oligonucleotides in cell culture, leaf cuttings and insects.
Michael holds both a DVM degree and a PhD in Ruminant Nutrition/Anaerobic Microbiology from Kansas State University. Most recently, he served as Vice President, Business Development for SmartVet Holdings, Inc., Olathe, Kansas, where he was responsible for new market development for the company’s proprietary VetGun and range of antiparasitics for cattle as well as management of technical and customer service. He was also instrumental in the company’s new product development initiatives.
His professional experience includes product and market development leadership for Merck Animal Health, Schering Plough Animal Health and Animal Profiling International.